Search

Qingyian Y Liu

from Camarillo, CA
Age ~56
Get Report
Also known as:
Qingyian Q Liu, Qingyian Liu Lu, Qing Yian Liu, Qing Yan Liu, Qing Y Liu, Qingyan Liu, Liu Lu Qingyian, N Liu, Yian Liu Qing
Phone and address:
4631 Paseo Girasol, Camarillo, CA 93012
(805) 482-5689
Related to:
Hongsheng Li, 60Zhengzhi Lu, 69Phuong B Chu, 54Jiantao T Lu, 56Xiaochuan Lu, 54Jinn Lui, 66Zhengzhi Li, 69Lifei F Chen, 48
Connected to:
Adela Liu, 73Alec X Liu, 38Alpha T Liu, 46Amon Y Liu, 58Andrea Y Liu, 46Anqi Liu, 39Arden K Liu, 64Ba S Liu, 62Bailu Liu, 35Ban Liu, 48

Qingyian Liu Phones & Addresses

  • 4631 Paseo Girasol, Camarillo, CA 93012 (805) 482-5689
  • Las Vegas, NV
  • Thousand Oaks, CA
  • Chicago, IL
  • Ventura, CA
  • 4631 Paseo Girasol, Camarillo, CA 93012

Education

Degree: High school graduate or higher

Publications

Us Patents

Substituted Piperazinyl Amides And Methods Of Use

View page
US Patent:
7115607, Oct 3, 2006
Filed:
Jul 24, 2002
Appl. No.:
10/202823
Inventors:
Christopher H. Fotsch - Thousand Oaks CA, US
Premilla Arasasingham - Thousand Oaks CA, US
Yunxin Bo - Thousand Oaks CA, US
Ning Chen - Thousand Oaks CA, US
Martin H. Goldberg - Woodland Hills CA, US
Nianhe Han - Thousand Oaks CA, US
Feng-Yin Hsieh - Thousand Oaks CA, US
Michael G. Kelly - Thousand Oaks CA, US
Qingyian Liu - Camarillo CA, US
Mark H. Norman - Thousand Oaks CA, US
Duncan M. Smith - Thousand Oaks CA, US
Markian Stec - Fillmore CA, US
Nuria Tamayo - Newbury Park CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Moorpark CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/496
C07D 401/12
C07D 403/12
US Classification:
51425213, 51425305, 51425306, 51425313, 51425409, 544359, 544363, 544365, 544373, 544376, 544379
Abstract:
Selected substituted piperazine compounds of Formula I are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Cyclic Amine Derivatives And Methods Of Use

View page
US Patent:
7199244, Apr 3, 2007
Filed:
Apr 12, 2004
Appl. No.:
10/823372
Inventors:
Robert D. Groneberg - Boulder CO, US
James Zhan - Shanghai, CN
Derin C. D'Amico - Newbury Park CA, US
Nianhe Han - Thousands Oaks CA, US
Christopher H. Fotsch - Thousands Oaks CA, US
Qingyian Liu - Camarillo CA, US
Babak Riahi - Woodland Hills CA, US
Jiawang Zhu - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Jian Jeffrey Chen - Newbury Park CA, US
Rana Nomak - Istanbul, TR
Assignee:
Amgen - Boulder CO
Array Biopharma Inc. - Boulder CO
International Classification:
C07D 211/08
C07D 405/00
US Classification:
546192, 548517, 514317, 514318, 514326
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Inhibitors Of 11-Β-Hydroxy Steroid Dehydrogenase Type 1

View page
US Patent:
7253196, Aug 7, 2007
Filed:
May 24, 2005
Appl. No.:
11/135662
Inventors:
Martin Henriksson - Uppsala, SE
Evert Homan - Sollentuna, SE
Lars Johansson - Stockholm, SE
Jerk Vallgarda - Uppsala, SE
Meredith Williams - Uppsala, SE
Eric A. Bercot - Moorpark CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Guolin Cai - Thousand Oaks CA, US
Randall W. Hungate - Camarillo CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Christopher Tegley - Thousand Oaks CA, US
David J. St. Jean, Jr. - Camarillo CA, US
Nianhe Han - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Qingyian Liu - Camarillo CA, US
Michael D. Bartberger - Sherman Oaks CA, US
George A. Moniz - Cambridge MA, US
Matthew J. Frizzle - Arlington MA, US
Assignee:
Amgen, Inc. - Thousand Oaks CA
Biovitrum AB - Stockholm
International Classification:
A61K 31/426
C07D 279/06
US Classification:
514369, 548182
Abstract:
The present invention relates to compounds with the formula (I), (II), (III) or (IV):.

Vanilloid Receptor Ligands And Their Use In Treatments

View page
US Patent:
7265138, Sep 4, 2007
Filed:
Feb 9, 2004
Appl. No.:
10/775980
Inventors:
Elizabeth M. Doherty - Newbury Park CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Nianhe Han - Thousand Oaks CA, US
Randall W. Hungate - Camarillo CA, US
Qingyian Liu - Camarillo CA, US
Mark H. Norman - Thousand Oaks CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/425
C07D 277/04
US Classification:
514365, 514374, 514396, 548146, 548215, 5483001
Abstract:
Compounds having the general structure.

Piperazine Derivatives And Methods Of Use

View page
US Patent:
7393852, Jul 1, 2008
Filed:
Jun 21, 2004
Appl. No.:
10/874086
Inventors:
Jian J. Chen - Newbury Park CA, US
Ben C. Askew - Newbury Park CA, US
Kaustav Biswas - Calabasas CA, US
Jennifer N. Chau - Santa Ana CA, US
Derin C. D'Amico - Newbury Park CA, US
Scott Harried - Woodland Hills CA, US
Thomas Nguyen - Thousand Oaks CA, US
Wenyuan Qian - Camarillo CA, US
Jiawang Zhu - Simi Valley CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Qingyian Liu - Camarillo CA, US
Nobuku Nishimura - West Hills CA, US
Tanya Peterkin - Woodland Hills CA, US
Babak Riahi - Woodland Hills CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Nianhe Han - Thousand Oaks CA, US
Rana Nomak - Westlake Village CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/54
A61K 31/4965
C07D 241/04
C07D 265/30
C07D 279/12
US Classification:
51425501, 5142275, 5142375, 544 59, 544158, 544384
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Compounds And Methods Of Use

View page
US Patent:
7425631, Sep 16, 2008
Filed:
Apr 12, 2004
Appl. No.:
10/823377
Inventors:
Robert D. Groneberg - Boulder CO, US
Derin C. D'Amico - Newbury Park CA, US
James Zhan - Shanghai, CN
Andras Toro - Toronto, CA
Youngboo Kim - Osaka, JP
David A. Mareska - Longmont CO, US
Nianhe Han - Thousands Oaks CA, US
Christopher H. Fotsch - Thousands Oaks CA, US
Qingyian Liu - Camarillo CA, US
Babak Riahi - Woodland Hills CA, US
Kevin Yang - San Gabriel CA, US
Aiwen Li - Westlake Village CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Kaustav Biswas - Calabasas CA, US
Scott Harried - Woodland Hills CA, US
Thomas Nguyen - Thousand Oaks CA, US
Wenyuan Qian - Camarillo CA, US
Jian Jeffrey Chen - Newbury Park CA, US
Rana Nomak - Westlake Village CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 215/04
US Classification:
546192, 548530, 548557, 549 51, 549 58, 549 59
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Thiazole Compounds And Methods Of Use

View page
US Patent:
7514566, Apr 7, 2009
Filed:
Jan 11, 2007
Appl. No.:
11/652728
Inventors:
Qingping Zeng - Thousand Oaks CA, US
John G. Allen - Newbury Park CA, US
Matthew P. Bourbeau - Woodland Hills CA, US
Celia Dominguez - Los Angeles CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Nianhe Han - Thousand Oaks CA, US
Xin Huang - Roslindale MA, US
Matthew R. Lee - Calabasas CA, US
Aiwen Li - Westlake Village CA, US
Qingyian Liu - Camarillo CA, US
James T. Rider - Camarillo CA, US
Seifu Tadesse - Simi Valley CA, US
Andrew S. Tasker - Simi Valley CA, US
Vellarkad N. Viswanadhan - Thousand Oaks CA, US
Xianghong Wang - Moorpark CA, US
Kurt E. Weiler - Thousand Oaks CA, US
George E. Wohlhieter - Lake Balboa CA, US
Guomin Yao - Newbury Park CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Assignee:
Amgen, Inc. - Thousand Oaks CA
International Classification:
A61K 31/425
C07D 277/00
US Classification:
548198, 514370
Abstract:
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.

Catalyzed Process Of Making C-5-Substituted Heterocyclic Inhibitors Of 11Β-Hydroxy Steroid Dehydrogenase Type 1

View page
US Patent:
7541474, Jun 2, 2009
Filed:
Nov 1, 2006
Appl. No.:
11/590922
Inventors:
Emilio Bunel - Thousand Oaks CA, US
Anil Guram - Oak Park CA, US
Qingyian Liu - Camarillo CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 277/08
C07D 263/08
US Classification:
548184, 548225
Abstract:
The invention provides a process for preparing 11 β-hydroxy steroid dehydrogenase type 1 inhibitors of formula 2 via a catalyzed reaction between a compound of formula 1 and a compound of formula RLG in the presence of base:.
Control profile
Qingyian Y Liu from Camarillo, CA, age ~56 Get Report